Back
Catalyst Pharmaceuticals, Inc. Vs. Structure Therapeutics, Inc. Industry Stock Comparison
Buy
81
CPRX
Catalyst Pharmaceuticals, Inc.
Last Price:
$24.43
Seasonality Move:
6.75%
Buy
63
GPCR
Structure Therapeutics, Inc.
Last Price:
$69.61
Seasonality Move:
-34.19%
Buy
81
Catalyst Pharmaceuticals, Inc. (CPRX)
is a Buy
Is Catalyst Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Catalyst Pharmaceuticals, Inc. [CPRX] share price is $24.23. The Score for CPRX is 81, which is 62% above its historic median score of 50, and infers lower risk than normal.
-
CPRX is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
63
Structure Therapeutics, Inc. (GPCR)
is a Buy
Is Structure Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Structure Therapeutics, Inc. [GPCR] share price is $71.29. The Score for GPCR is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
GPCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CPRX Stock Price Chart
What is Catalyst Pharmaceuticals, Inc.'s stock price today?
-
The Catalyst Pharmaceuticals, Inc. share price today is $24.23Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CPRX is experiencing slight selling pressure.
GPCR Stock Price Chart
What is Structure Therapeutics, Inc.'s stock price today?
-
The Structure Therapeutics, Inc. share price today is $71.29Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing buying pressure, which is a positive indicator for future bullish movement.
CPRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.48 | Buy |
| Relative Strength Index (14 RSI): | 62.65 | Buy |
| Chaikin Money Flow: | -283222 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.78 - 23.9) | Buy |
| Bollinger Bands (100): | (19.93 - 22.75) | Buy |
GPCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.5 | Buy |
| Relative Strength Index (14 RSI): | 72.85 | Buy |
| Chaikin Money Flow: | 1903413 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.41 - 65.27) | Buy |
| Bollinger Bands (100): | (17 - 45.24) | Buy |
CPRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.99 | Buy |
| 20-day SMA: | 23.44 | Buy |
| 50-day SMA: | 22.4 | Buy |
| 200-day SMA: | 22.17 | Buy |
| 8-day EMA: | 23.9 | Buy |
| 20-day EMA: | 23.47 | Buy |
| 50-day EMA: | 22.29 | Buy |
| 200-day EMA: | 14.02 | Buy |
GPCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 64.43 | Buy |
| 20-day SMA: | 52.92 | Buy |
| 50-day SMA: | 40.28 | Buy |
| 200-day SMA: | 26.09 | Buy |
| 8-day EMA: | 64 | Buy |
| 20-day EMA: | 55.88 | Buy |
| 50-day EMA: | 44.22 | Buy |
| 200-day EMA: | 31.26 | Buy |
Catalyst Pharmaceuticals, Inc. Earnings Growth & CPRX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and an increase next year of $0.08 per share.
Structure Therapeutics, Inc. Earnings Growth & GPCR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.48 per share, and a decrease next year of $0.10 per share.
Catalyst Pharmaceuticals, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Structure Therapeutics, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||